This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.90% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Organon Secures FDA Approval Extending NEXPLANON Use to Five Years
by Zacks Equity Research
OGN wins FDA approval to extend NEXPLANON use to five years, backed by trials showing no pregnancies and strong efficacy across body weights.
CRLPositive Net Change MDPositive Net Change ATRCNegative Net Change OGNPositive Net Change
medical medical-devices
Here's Why You Should Retain CLOV Stock in Your Portfolio for Now
by Zacks Equity Research
Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.
CRLPositive Net Change MDPositive Net Change ATRCNegative Net Change CLOVPositive Net Change
medical medical-devices
New Strong Sell Stocks for January 20th
by Zacks Equity Research
DAR, CADL and DRTS have been added to the Zacks Rank #5 (Strong Sell) List on January 20, 2026.
DARPositive Net Change CADLPositive Net Change DRTSNegative Net Change
consumer-staples medical medical-devices
Should You Still Hold GMED Stock in Your Portfolio?
by Zacks Equity Research
Globus Medical is growing musculoskeletal market share with new product launches, strong finances and international expansion plans.
BSXPositive Net Change GMEDNegative Net Change PAHCPositive Net Change NVSTNegative Net Change
medical medical-devices
How Tilray Brands Is Acting on Its Vast International Opportunity
by Moumi Mondal
TLRY posts a standout international quarter as cannabis revenues jump 36% year over year, driving supply shifts and broader global expansion.
TLRYNegative Net Change VFFPositive Net Change SNDLNegative Net Change
medical medical-devices
Elekta Wins FDA Nod for Evo CT-Linac, Boosting U.S. Radiation Oncology
by Zacks Equity Research
EKTAY jumps after FDA clears Evo CT-Linac, opening U.S. access to AI-driven CT imaging that boosts precision and efficiency in radiation therapy.
ISRGNegative Net Change ATRCNegative Net Change EKTAYNegative Net Change VCYTNegative Net Change
medical medical-devices
SNN Boosts Shoulder Repair Portfolio With Integrity Orthopaedics Deal
by Zacks Equity Research
SNN expands its Sports Medicine portfolio with Integrity Orthopaedics, adding next-gen Tendon Seam tech to strengthen leadership in shoulder repair.
BSXPositive Net Change SNNNegative Net Change IDXXNegative Net Change STENegative Net Change
medical medical-devices
Here's Why You Should Hold DaVita Stock in Your Portfolio for Now
by Zacks Equity Research
DVA stock benefits from a patient-centric model, third-quarter revenue growth and overseas expansion, though reliance on commercial payers remains a risk.
BSXPositive Net Change DVANegative Net Change IDXXNegative Net Change STENegative Net Change
medical medical-devices
Hims & Hers Expands Platform-Led Access to Digital Healthcare
by Debanjana Dey
HIMS leverages a software-driven platform to scale personalized digital care across new health categories and markets.
TDOCNegative Net Change AMWLNegative Net Change HIMSNegative Net Change
medical medical-devices
AI, Digital Tools and Hub Data: Could ISRG Evolve Beyond Robotics?
by Indrajit Bandyopadhyay
Intuitive Surgical is positioning da Vinci 5 as a data-driven platform, using AI, software and surgical data to expand beyond robotics into insights.
BSXPositive Net Change ISRGNegative Net Change GEHCNegative Net Change
medical medical-devices
HOLX vs. SYK: Which Medical Device Leader Is a Solid Bet Now?
by Moumi Mondal
Hologic and Stryker gear up for earnings with diagnostic wins, surgical growth and strategic moves shaping the medical device race.
SYKNegative Net Change HOLXNegative Net Change
medical medical-devices
3 Undervalued Medical Instrument Stocks Poised to Grow in 2026
by Indrajit Bandyopadhyay
FMS, IART and STE trade below historical valuations. Easing cost pressure and improved execution set the stage for potential upside in 2026 for these companies.
IARTNegative Net Change FMSNegative Net Change STENegative Net Change
medical medical-devices
Top Analyst Reports for Visa, AMD & Thermo Fisher
by Mark Vickery
Visa's volume-driven growth, cross-border expansion and AI investments support long-term prospects, but rising costs and regulatory risks keep the outlook cautious.
AMDPositive Net Change VNegative Net Change MCONegative Net Change TMONegative Net Change CAHPositive Net Change PSXPositive Net Change
business-services computers medical-devices
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results
by Zacks Equity Research
ISRG posts strong preliminary Q4 and full-year 2025 revenue growth, but shares dip as investors weigh procedure trends, margins and outlook.
BSXPositive Net Change ISRGNegative Net Change CAHPositive Net Change ATRCNegative Net Change
medical medical-devices
DexCom Stock Declines Following Strong Preliminary Q4 Results
by Zacks Equity Research
DXCM posts strong preliminary Q4 and full-year 2025 revenue growth, beating estimates, though shares slip after the announcement.
BSXPositive Net Change CAHPositive Net Change DXCMPositive Net Change ATRCNegative Net Change
medical medical-devices
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
by Zacks Equity Research
DXCM looks poised for growth as CGM demand expands, G7 and One+ adoption accelerates, and strong Q4 results support a hold stance.
OMCLNegative Net Change DXCMPositive Net Change ATRCNegative Net Change PAHCPositive Net Change
medical medical-devices
3 Undervalued Medical Instrument Stocks Poised to Grow in 2026
by Indrajit Bandyopadhyay
FMS, IART and STE trade below historical valuations. Easing cost pressure and improved execution set the stage for potential upside in 2026 for these companies.
IARTNegative Net Change FMSNegative Net Change STENegative Net Change
medical medical-devices
The Zacks Analyst Blog Highlights American Express, Intuitive Surgical, Booking Holdings, Daily Journal and Star Group
by Zacks Equity Research
American Express shows steady growth from travel spending and new products, even as rising costs and credit risks temper upside.
AXPNegative Net Change ISRGNegative Net Change SGUPositive Net Change DJCONegative Net Change BKNGNegative Net Change
computers consumer-staples finance medical-devices retail
Hologic Leads Campaign to Emphasize Routine Cervical Cancer Screening
by Moumi Mondal
HOLX launches Ultimate Defense, a new U.S. campaign that urges routine Pap + HPV screening to boost awareness and help curb rising underscreening.
BSXPositive Net Change MDTPositive Net Change HOLXNegative Net Change
medical medical-devices
Top Stock Reports for American Express, Intuitive Surgical & Booking
by Mark Vickery
American Express, Intuitive Surgical and Booking anchor today's Zacks Research Daily, spotlighting performance drivers, growth trends and key risks.
FASTNegative Net Change AXPNegative Net Change ISRGNegative Net Change TTWOPositive Net Change SCCOPositive Net Change SGUPositive Net Change DJCONegative Net Change BKNGNegative Net Change
computers consumer-staples finance medical-devices retail
Weekly Option Windfall: Leading Medical Imaging Giant Offers Attractive Entry
by Bryan Hayes
The rise of GEHC reflects its strong positioning in imaging, patient monitoring, and pharmaceutical diagnostics.
GEHCNegative Net Change
artificial-intelligence hospitals medical medical-devices options pharmaceuticals smart-health
CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026
by Zacks Equity Research
Clover Health posts 53% AEP PPO membership growth, lifts total members to 153,000, and says the momentum positions it for GAAP net income profitability in 2026.
OMCLNegative Net Change ATRCNegative Net Change PAHCPositive Net Change CLOVPositive Net Change
medical medical-devices
Masimo Stock Declines Despite Solid Preliminary Q4 Revenues
by Zacks Equity Research
MASI posts strong fourth-quarter and full-year 2025 preliminary results with revenue and EPS above estimates, driven by core healthcare momentum.
BSXPositive Net Change CAHPositive Net Change MASIPositive Net Change IDXXNegative Net Change
earnings medical medical-devices
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
by Zacks Equity Research
QDEL's decent Q3 2025 results and expanding diagnostics portfolio support near-term growth despite respiratory reliance and payer risks.
BSXPositive Net Change IDXXNegative Net Change QDELNegative Net Change STENegative Net Change
medical medical-devices
PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research
by Zacks Equity Research
PACB stock jumps as HiFi whole-genome sequencing becomes first-line in major SUDC research, highlighting adoption momentum.
BSXPositive Net Change IDXXNegative Net Change STENegative Net Change PACBPositive Net Change
medical medical-devices